Toxic metabolite formation from troglitazone (TGZ): New insights from a DFT study

Chemical Research in Toxicology

Volumn 24, Issue 7, 2011, Pages 1113-1122

  Dixit, Vaibhav A ^a   Bharatam, Prasad V ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

[No Author keywords available]

Indexed keywords

6 HYDROXY 2,2,5,7,8 PENTAMETHYLCHROMANE; CARBENE; CARBON 13; CARBON 14; CHROMAN DERIVATIVE; DRUG METABOLITE; HYDROGEN PEROXIDE; HYDROXYL GROUP; METHYL GROUP; O QUINONE METHIDE; QUINONE DERIVATIVE; QUINONE METABOLITE; TROGLITAZONE; UNCLASSIFIED DRUG;

ARTICLE; ATOM; ELECTROPHILICITY; OXIDATION; QUANTUM CHEMISTRY; REACTION ANALYSIS;

CHROMANS; HYDROGEN PEROXIDE; INDOLEQUINONES; OXIDATION-REDUCTION; QUANTUM THEORY; QUINONES; THERMODYNAMICS; THIAZOLIDINEDIONES;

EID: 79960474729     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx200110h     Document Type: Article

References (64)

1. Sohda, T., Mizuno, K., Imamiya, E., Tawada, H., Meguro, K., Kawamatsu, Y., and Yamamoto, Y. (1982) Studies on antidiabetic agents. III. 5-Arylthiazolidine-2,4-diones as potent aldose reductase inhibitors Chem. Pharm. Bull. 30, 3601-3616 (Pubitemid 13210098)
2. Nolan, J. J., Ludvik, B., Beerdsen, P., Joyce, M., and Olefsky, J. (1994) Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone N. Engl. J. Med. 331, 1188
3. Gale, E. A. M. (2001) Lessons from the glitazones: a story of drug development The Lancet 357, 1870-1875 (Pubitemid 32539124)
4. Rosen, C. J. (2007) The rosiglitazone story: lessons from an FDA Advisory Committee meeting N. Engl. J. Med. 357, 844-846 (Pubitemid 47347317)
5. Lebovitz, H. E., Kreider, M., and Freed, M. I. (2002) Evaluation of liver function in type 2 diabetic patients during clinical trials: Evidence that rosiglitazone does not cause hepatic dysfunction Diabetes Care 25, 815-821 (Pubitemid 41094276)
6. Scheen, A. J. (2001) Thiazolidinediones and liver toxicity Diabetes Metab. 27, 305-314
7. Sheehan, M. T. (2003) Current therapeutic options in type 2 diabetes mellitus: a practical approach Clin. Med. Res. 1, 189
8. Kaul, S. and Diamond, G. A. (2010) Diabetes: Breaking news! Rosiglitazone and cardiovascular risk Nat. Rev. Cardiol. 7, 670-672
9. Masubuchi, Y. (2006) Metabolic and non-metabolic factors determining troglitazone hepatotoxicity: a review Drug Metab. Pharmacokinet. 21, 347-356
10. Smith, M. T. (2003) Mechanisms of troglitazone hepatotoxicity Chem. Res. Toxicol. 16, 679-687 (Pubitemid 36736599)
11. Sahi, J., Black, C. B., Hamilton, G. A., Zheng, X., Jolley, S., Rose, K. A., Gilbert, D., LeCluyse, E. L., and Sinz, M. W. (2003) Comparative effects of thiazolidinediones on in vitro P450 enzyme induction and inhibition Drug Metab. Dispos. 31, 439
12. Kawai, K., Kawasaki-Tokui, Y., Odaka, T., Tsuruta, F., Kazui, M., Iwabuchi, H., Nakamura, T., Kinoshita, T., Ikeda, T., and Yoshioka, T. (1997) Disposition and metabolism of the new oral antidiabetic drug troglitazone in rats, mice and dogs Arzneim.-Forsch. 47, 356-368 (Pubitemid 27207306)
13. Brigelius-Flohe, R. and Traber, M. G. (1999) Vitamin E: function and metabolism FASEB J. 13, 1145
14. Kassahun, K., Pearson, P. G., Tang, W., McIntosh, I., Leung, K., Elmore, C., Dean, D., Wang, R., Doss, G., and Baillie, T. A. (2001) Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinone methide formation and thiazolidinedione ring scission Chem. Res. Toxicol. 14, 62-70 (Pubitemid 32064376)
15. Bolton, J. L., Trush, M. A., Penning, T. M., Dryhurst, G., and Monks, T. J. (2000) Role of quinones in toxicology Chem. Res. Toxicol. 13, 135-160 (Pubitemid 30169958)
16. Weinert, E. E., Frankenfield, K. N., and Rokita, S. E. (2005) Time-dependent evolution of adducts formed between deoxynucleosides and a model quinone methide Chem. Res. Toxicol. 18, 1364-1370 (Pubitemid 41361709)
17. Yamamoto, Y., Yamazaki, H., Ikeda, T., Watanabe, T., Iwabuchi, H., Nakajima, M., and Yokoi, T. (2002) Formation of a novel quinone epoxide metabolite of troglitazone with cytotoxic to HepG2 cells Drug Metab. Dispos. 30, 155
18. Bolton, J. L., Acay, N. M., and Vukomanovic, V. (1994) Evidence that 4-allyl-o-quinones spontaneously rearrange to their more electrophilic quinone methides: potential bioactivation mechanism for the hepatocarcinogen safrole Chem. Res. Toxicol. 7, 443-450 (Pubitemid 24150107)
19. Khdour, O. and Skibo, E. B. (2009) Quinone methide chemistry of prekinamycins: 13C- labeling, spectral global fitting and in vitro studies Org. Biomol. Chem. 7, 2140-2154
20. Angle, S. R., Rainier, J. D., and Woytowicz, C. (1997) Synthesis and chemistry of quinone methide models for the anthracycline antitumor antibiotics J. Org. Chem. 62, 5884-5892 (Pubitemid 27375208)
21. Di Antonio, M., Doria, F., Richter, S. N., Bertipaglia, C., Mella, M., Sissi, C., Palumbo, M., and Freccero, M. (2009) Quinone methides tethered to naphthalene diimides as selective G-quadruplex alkylating agents J. Am. Chem. Soc. 131, 13132-13141
22. Doria, F., Richter, S. N., Nadai, M., Colloredo-Mels, S., Mella, M., Palumbo, M., and Freccero, M. (2007) BINOL-amino acid conjugates as triggerable carriers of DNA-targeted potent photocytotoxic agents J. Med. Chem. 50, 6570-6579 (Pubitemid 350309096)
23. Ferreira, S. B., da Silva, F. d. C., Pinto, A. C., Gonzaga, D. T. G., and Ferreira, V. F. (2009) Syntheses of chromenes and chromanes via o-quinone methide intermediates J. Heterocycl. Chem. 46, 1080-1097
24. Chiang, Y., Kresge, A. J., and Zhu, Y. (2000) Reactive intermediates. Some chemistry of quinone methides Pure Appl. Chem. 72, 2299-2308
25. Awad, H. M., Boersma, M. G., Boeren, S., van Bladeren, P. J., Vervoort, J., and Rietjens, I. M. C. M. (2001) Structure activity study on the quinone/quinone methide chemistry of flavonoids Chem. Res. Toxicol. 14, 398-408 (Pubitemid 32367473)
26. Madsen, K. G., Gro nberg, G., Skonberg, C., Jurva, U., Hansen, S. H., and Olsen, J. (2008) Electrochemical oxidation of troglitazone: identification and characterization of the major reactive metabolite in liver microsomes Chem. Res. Toxicol. 21, 2035-2041
27. Cox, P. J., Ryan, D. A., Hollis, F. J., Harris, A. M., Miller, A. K., Vousden, M., and Cowley, H. (2000) Absorption, disposition, and metabolism of rosiglitazone, a potent thiazolidinedione insulin sensitizer, in humans Drug Metab. Dispos. 28, 772
28. Scheen, A. J. (2001) Hepatotoxicity with thiazolidinediones: Is it a class effect? Drug Safety 24, 873-888 (Pubitemid 33078194)
29. Tolman, K. G. (2000) Thiazolidinedione hepatotoxicity: A class effect? Int. J. Clin. Pract. 29-34
30. Reddy, V. B. G., Karanam, B. V., Gruber, W. L., Wallace, M. A., Vincent, S. H., Franklin, R. B., and Baillie, T. A. (2005) Mechanistic studies on the metabolic scission of thiazolidinedione derivatives to acyclic thiols Chem. Res. Toxicol. 18, 880-888 (Pubitemid 40705455)
31. Alvarez-Sanchez, R., Montavon, F., Hartung, T., and Pahler, A. (2006) Thiazolidinedione bioactivation: A comparison of the bioactivation potentials of troglitazone, rosiglitazone, and pioglitazone using stable isotope-labeled analogues and liquid chromatography tandem mass spectrometry Chem. Res. Toxicol. 19, 1106-1116 (Pubitemid 44384842)
32. Saha, S., New, L. S., Ho, H. K., Chui, W. K., and Chan, E. C. Y. (2010) Investigation of the role of the thiazolidinedione ring of troglitazone in inducing hepatotoxicity Toxicol. Lett. 192, 141-149
33. Ramachandran, V., Kostrubsky, V. E., Komoroski, B. J., Zhang, S., Dorko, K., Esplen, J. E., Strom, S. C., and Venkataramanan, R. (1999) Troglitazone increases cytochrome P-450 3A protein and activity in primary cultures of human hepatocytes Drug Metab. Dispos. 27, 1194-1199 (Pubitemid 29463607)
34. Li, J., Kaneko, T., Wang, Y., Qin, L.-Q., Wang, P.-Y., and Sato, A. (2002) Troglitazone enhances the hepatotoxicity of acetaminophen by inducing CYP3A in rats Toxicology 176, 91-100 (Pubitemid 34626733)
35. Prescott, L. F., Roscoe, P., Wright, N., and Brown, S. S. (1971) Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage Lancet 1, 519-522
36. Loew, G. H. and Goldblum, A. (1985) Metabolic activation and toxicity of acetaminophen and related analogs. A theoretical study Mol. Pharmacol. 27, 375-386 (Pubitemid 15142336)
37. Boersma, M. G., Vervoort, J., Szymusiak, H., Lemanska, K., Tyrakowska, B., Cenas, N., Segura-Aguilar, J., and Rietjens, I. M. C. M. (2000) Regioselectivity and reversibility of the glutathione conjugation of quercetin quinone methide Chem. Res. Toxicol. 13, 185-191 (Pubitemid 30169963)
38. Brzostowska, E. M., Paulynice, M., Bentley, R., and Greer, A. (2007) Planar chirality due to a polysulfur ring in natural pentathiepin cytotoxins. Implications of planar chirality for enantiospecific biosynthesis and toxicity Chem. Res. Toxicol. 20, 1046-1052 (Pubitemid 47204818)
39. Chattaraj, P. K., Sarkar, U., and Roy, D. R. (2006) Electrophilicity index Chem. Rev. 106, 2065-2091
40. Freccero, M., Gandolfi, R., and Sarzi-Amada, M. (2003) Selectivity of purine alkylation by a quinone methide. Kinetic or thermodynamic control? J. Org. Chem. 68, 6411-6423 (Pubitemid 36961032)
41. Huetz, P., Mavaddat, N., and Mavri, J. (2005) Reaction between ellagic acid and an ultimate carcinogen J. Chem. Inf. Model 45, 1564-1570 (Pubitemid 41784724)
42. Roy, D. R., Parthasarathi, R., Maiti, B., Subramanian, V., and Chattaraj, P. K. (2005) Electrophilicity as a possible descriptor for toxicity prediction Bioorg. Med. Chem. 13, 3405-3412 (Pubitemid 40545795)
43. Sarkar, U., Roy, D., Chattaraj, P., Parthasarathi, R., Padmanabhan, J., and Subramanian, V. (2005) A conceptual DFT approach towards analysing toxicity J. Chem. Sci. 117, 599-612 (Pubitemid 41658956)
44. Shim, J.-Y. and Richard, A. M. (1997) Theoretical evaluation of two plausible routes for bioactivation of S-(1,1-difluoro-2,2-dihaloethyl)-l- cysteine conjugates: thiirane vs thionoacyl fluoride pathway Chem. Res. Toxicol. 10, 103-110 (Pubitemid 27044914)
45. Torres, R. A., Korzekwa, K. R., McMasters, D. R., Fandozzi, C. M., and Jones, J. P. (2007) Use of density functional calculations to predict the regioselectivity of drugs and molecules metabolized by aldehyde oxidase J. Med. Chem. 50, 4642-4647 (Pubitemid 47463238)
46. Valentin, C. D., Freccero, M., Zanaletti, R., and Sarzi-Amada, M. (2001) o-Quinone methide as alkylating agent of nitrogen, oxygen, and sulfur nucleophiles. The role of H-bonding and solvent effects on the reactivity through a DFT computational study J. Am. Chem. Soc. 123, 8366-8377 (Pubitemid 32916411)
47. Frisch, M. J., Rega, N., Petersson, G. A., Trucks, G. W., Nakatsuji, H., Hada, M., Ehara, M., Toyota, K., Fukuda, R., Hasegawa, J., Ishida, M., Burant, J. C., Nakajima, T., Honda, Y., Kitao, O., Schlegel, H. B., Nakai, H., Klene, M., Li, X., Knox, J. E., Hratchian, H. P., Cross, J. B., Millam, J. M., Bakken, V., Adamo, C., Jaramillo, J., Gomperts, R., Scuseria, G. E., Stratmann, R. E., Yazyev, O., Austin, A. J., Cammi, R., Pomelli, C., Iyengar, S. S., Ochterski, J. W., Ayala, P. Y., Morokuma, K., Voth, G. A., Salvador, P., Robb, M. A., Dannenberg, J. J., Zakrzewski, V. G., Dapprich, S., Daniels, A. D., Tomasi, J., Strain, M. C., Farkas, O., Malick, D. K., Rabuck, A. D., Raghavachari, K., Foresman, J. B., Cheeseman, J. R., Ortiz, J. V., Cui, Q., Baboul, A. G., Barone, V., Clifford, S., Cioslowski, J., Stefanov, B. B., Liu, G., Liashenko, A., Piskorz, P., Komaromi, I., Montgomery, Jr., J. A., Martin, R. L., Fox, D. J., Mennucci, B., Keith, T., Al-Laham, M. A., Peng, C. Y., Nanayakkara, A., Challacombe, M., Gill, P. M. W., Johnson, B., Chen, W., Vreven, T., Wong, M. W., Cossi, M., Gonzalez, C., Pople, J. A., Kudin, K. N., and Scalmani, G. (2004) Gaussian 03, revision C.02, Gaussian Inc., Wallingford, CT.
48. Scott, A. P. and Radom, L. (1996) Harmonic vibrational frequencies: An evaluation of Hartree-Fock, Moller-Plesset, quadratic configuration interaction, density functional theory, and semiempirical scale factors J. Phys. Chem. 100, 16502-16513 (Pubitemid 126787989)
49. Reed, A. E., Weinstock, R. B., and Weinhold, F. (1985) Natural population analysis J. Chem. Phys. 83, 735-746
50. Alvarez-Sanchez, R., Montavon, F., Hartung, T., and Pahler, A. (2006) Thiazolidinedione bioactivation: A comparison of the bioactivation potentials of troglitazone, rosiglitazone, and pioglitazone using stable isotope-labeled analogues and liquid chromatography tandem mass spectrometry Chem. Res. Toxicol. 19, 1106-1116 (Pubitemid 44384842)
51. Shaik, S., Cohen, S., Wang, Y., Chen, H., Kumar, D., and Thiel, W. (2010) P450 enzymes: their structure, reactivity, and selectivity - modeled by QM/MM calculations Chem. Rev. 110, 949-1017
52. Afzelius, L., Arnby, C. H., Broo, A., Carlsson, L., Isaksson, C., Jurva, U., Kjellander, B., Kolmodin, K., Nilsson, K., and Raubacher, F. (2007) State-of-the-art tools for computational site of metabolism predictions: Comparative analysis, mechanistical insights, and future applications Drug Metab. Rev. 39, 61-86
53. Luzhkov, V. B. (2005) Mechanisms of antioxidant activity: The DFT study of hydrogen abstraction from phenol and toluene by the hydroperoxyl radical Chem. Phys. 314, 211-217 (Pubitemid 40631012)
54. Klein, E. and Lukes, V. (2006) Study of gas-phase OH bond dissociation enthalpies and ionization potentials of substituted phenols-Applicability of ab initio and DFT/B3LYP methods Chem. Phys. 330, 515-525
55. Klein, E. and Lukes, V. (2006) DFT/B3LYP study of OH bond dissociation enthalpies of para and meta substituted phenols: Correlation with the phenolic CO bond length J. Mol. Struct.: Theochem. 767, 43-50
56. McFerrin, C. A., Hall, R. W., and Dellinger, B. (2008) Ab initio study of the formation and degradation reactions of semiquinone and phenoxyl radicals J. Mol. Struct.: Theochem. 848, 16-23
57. Klein, E., Lukes, V., and Ilcin, M. (2007) DFT/B3LYP study of tocopherols and chromans antioxidant action energetics Chem. Phys. 336, 51-57
58. Ingold, K. U. and Wright, J. S. (2000) Understanding trends in CH, NH, and OH bond dissociation enthalpies J. Chem. Educ. 77, 1062-1064
59. Gansäuer, A. and Zipse, H. (2006) Radical Stability - A Theoretical Perspective, in Radicals in Synthesis I, pp 163-189, Springer, Berlin, Germany.
60. Weinert, E. E., Dondi, R., Colloredo-Melz, S., Frankenfield, K. N., Mitchell, C. H., Freccero, M., and Rokita, S. E. (2006) Substituents on quinone methides strongly modulate formation and stability of their nucleophilic adducts J. Am. Chem. Soc. 128, 11940-11947 (Pubitemid 44360231)
61. Wang, H. and Rokita, S. E. (2010) Dynamic cross-linking is retained in duplex dna after multiple exchange of strands Angew. Chem., Int. Ed. 49, 5957-5960
62. Rittle, J. and Green, M. T. (2010) Cytochrome P450 compound I: capture, characterization, and C-H bond activation kinetics Science 330, 933-937
63. Fukui, K. (1982) Role of frontier orbitals in chemical reactions Science 218, 747-754
64. Parr, R. G. and Yang, W. (1984) Density functional approach to the frontier-electron theory of chemical reactivity J. Am. Chem. Soc. 106, 4049-4050